Postoperative Pericardial Cyst Enlargement After Recurrent Breast Cancer
- 1Department of Clinical Sciences, San Juan Bautista School of Medicine, Caguas, Puerto Rico
- 2Division of Cardiology, Department of Medicine, Heart and Vascular Institute, Brigham and Women’s Hospital, Mass General Brigham and Harvard Medical School, Boston, Massachusetts, USA
Abstract
Background: Pericardial cysts (PCs) are benign congenital anomalies typically managed conservatively. Interval enlargement in patients with active malignancy may mimic metastatic pericardial involvement.
Case Summary: A 52-year-old woman with previously treated right-sided ductal carcinoma in situ presented with new ipsilateral breast lobular carcinoma. A right-sided pericardial lesion was incidentally identified during workup, and cardiac-gated computed tomography characterized this as a PC. Seven months after bilateral mastectomies and adjuvant chemoradiation, the patient underwent bilateral breast reconstruction. A postoperative computed tomography showed interval enlargement of the pericardial lesion, raising concern for possible residual malignant disease. Clinically, the patient remained asymptomatic, and multimodal imaging over the next month showed interval size regression, supporting a diagnosis of benign PC with inflammation-related size change.
Discussion: PC enlargement during recurrent malignancy may mimic metastatic pericardial disease; however, prevalent benign etiologies should be ruled out. Multimodal imaging and clinical evaluation are key in determining benign vs malignant pathology.
Related
- Development and internal validation of a machine learning prediction model for postoperative hemorrhage following modified radical mastectomy for breast cancer
- Safety of concurrent immune checkpoint inhibitor therapy during postoperative radiotherapy for triple-negative breast cancer: A preliminary retrospective analysis
- Rapidly Recurrent Fibrous Gingival Enlargement in a Geriatric Patient: Clinical Significance of Recurrence Timing
- From Lethargy to Recovery: Central Diabetes Insipidus from Pituitary Metastasis in Recurrent HER2-Positive Breast Cancer Treated with Fam-Trastuzumab Deruxtecan-Nxki
- Dynamic ctDNA-MRD in breast cancer: subtype-specific implications for perioperative decision-making, postoperative surveillance, and MRD-guided therapy.
BibTeX
@article{naoun2026postoperative,
title = {{Postoperative Pericardial Cyst Enlargement After Recurrent Breast Cancer}},
author = {Adrian A. Naoun and Arvind K. Pandey},
journal = {JACC Case Reports},
year = {2026},
month = aug,
doi = {10.1016/j.jaccas.2026.109932},
url = {https://doi.org/10.1016/j.jaccas.2026.109932},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Postoperative Pericardial Cyst Enlargement After Recurrent Breast Cancer
AU - Adrian A. Naoun
AU - Arvind K. Pandey
PY - 2026
DA - 2026/08/29
JO - JACC Case Reports
DO - 10.1016/j.jaccas.2026.109932
UR - https://doi.org/10.1016/j.jaccas.2026.109932
AB - Background: Pericardial cysts (PCs) are benign congenital anomalies typically managed conservatively. Interval enlargement in patients with active malignancy may mimic metastatic pericardial involvement. Case Summary: A 52-year-old woman with previously treated right-sided ductal carcinoma in situ presented with new ipsilateral breast lobular carcinoma. A right-sided pericardial lesion was incidentally identified during workup, and cardiac-gated computed tomography characterized this as a PC. Seven months after bilateral mastectomies and adjuvant chemoradiation, the patient underwent bilateral breast reconstruction. A postoperative computed tomography showed interval enlargement of the pericardial lesion, raising concern for possible residual malignant disease. Clinically, the patient remained asymptomatic, and multimodal imaging over the next month showed interval size regression, supporting a diagnosis of benign PC with inflammation-related size change. Discussion: PC enlargement during recurrent malignancy may mimic metastatic pericardial disease; however, prevalent benign etiologies should be ruled out. Multimodal imaging and clinical evaluation are key in determining benign vs malignant pathology.
SN - 2666-0849
ER -